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Transforming growth factor 1 (TGF1) is a pleiotropic cytokine with potent neurotrophic and immunosuppressive properties that is
upregulatedafter injury, but also expressed in thenormalnervous system. In the current study,we examined the regulationofTGF1and
the effects of TGF1 deletion on cellular response in the uninjured adult brain and in the injured and regenerating facial motor nucleus.
To avoid lethal autoimmune inflammation within 3 weeks after birth in TGF1-deficient mice, this study was performed on a T- and
B-cell-deficient RAG2/ background. Compared with wild-type siblings, homozygous deletion of TGF1 resulted in an extensive
inflammatory response in otherwise uninjured brain parenchyma. Astrocytes increased inGFAP andCD44 immunoreactivity;microglia
showed proliferative activity, expression of phagocytosis-associated markers [X2, B7.2, and MHC1 (major histocompatibility com-
plex type 1)], and reduced branching. Ultrastructural analysis revealed focal blockade of axonal transport, perinodal damming of axonal
organelles, focal demyelination, andmyelin debris in granule-rich, phagocytic microglia. After facial axotomy, absence of TGF1 led to
a fourfold increase in neuronal cell death (52 vs 13%), decreased central axonal sprouting, and significant delay in functional recovery. It
also interfered with the microglial response, resulting in a diminished expression of early activation markers [ICAM1 (intercellular
adhesionmolecule 1),61, andM2] and reducedproliferation. In linewith axonal and glial findings in the otherwise uninjuredCNS,
absenceof endogenousTGF1 also causedan10%reduction in thenumberof normalmotoneurons, pointing to anongoing andpotent
trophic role of this anti-inflammatory cytokine in the normal as well as in the injured brain.
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Introduction
Neuroglial activation is a hallmark of CNS injury, accompanying
almost all neuropathologies and experimental brain lesions (Big-
nami, 1984; Graeber and Kreutzberg, 1988; Perry and Gordon,
1988). After injury, activated microglia rapidly proliferate (Raiv-
ich et al., 1994), migrate to the affected site, and adhere to the
injured neurons (Kalla et al., 2001), displacing the neurite termi-
nals in a process known as synaptic stripping (Blinzinger and
Kreutzberg, 1968; Trapp et al., 2007). After synaptic stripping, the
microglia gradually migrate into the nearby parenchyma, where
they appear to downregulate their cellular markers and decrease
in number (Jones et al., 1997). Parallel to the microglial activa-
tion, reactive astrocytes show a rapid increase in signaling recep-
tors, neurotrophins, growth factors, and extracellular matrix
proteins, all of which play an important regulatory role in the
repair and regeneration process (Eddleston and Mucke, 1993).
Although several key molecules like MCSF (macrophage colony-
stimulating factor) and IL-6 (interleukin-6) have been identified
for their role in the activation of microglia and astrocytes after
neural injury (Raivich et al., 1994; Klein et al., 1997; Galiano et al.,
2001; Kalla et al., 2001), little is known about the endogenous
signals involved in the downregulation of these glial cells after
injury, as well as their persistently downregulated state in the
uninjuredCNS.One candidatemolecule here is the immunosup-
pressive cytokine transforming growth factor  1 (TGF1).
TGF1 is a potent, pleiotropic cytokine, involved in several
biological processes affecting growth and differentiation (Mas-
sague´, 1990; Roberts and Sporn, 1990; Bommireddy and
Doetschman, 2004). In the CNS, TGF1 has been shown to pro-
mote the survival of embryonic, neonatal, and adult neurons
(Martinou et al., 1990; Oppenheim et al., 1993; Boche et al., 2003;
Schober et al., 2007), assist in neurite outgrowth (Ishihara et al.,
1994; Abe et al., 1996), protect against experimental allergic en-
cephalomyelitis (Racke et al., 1991; Johns and Sriram, 1993; San-
tambrogio et al., 1993), and inhibit microglial and astrocyte pro-
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liferation (Lindholm et al., 1992; Vergeli et al., 1995). Studies
using ramified microglia grown on an astrocyte monolayer also
demonstrated the strong inhibitory effect of TGF1 on micro-
glial proliferation (Jones et al., 1998), agreeing with reports in
vivo that suggest that TGF1 is responsible for the downregula-
tion of the microglial response after injury (Kiefer et al., 1993a;
Morgan et al., 1993).
Although TGF1 levels are strongly and rapidly upregulated
after different forms of injury like cortical incision, entorhinal
lesion, ischemia, experimental allergic neuritis, or peripheral
axotomy (Nichols et al., 1991; Klempt et al., 1992; Kiefer et al.,
1993a,b; Logan et al., 1994), TGF1 is also present in moderately
high levels even in the normal, uninjured adult brain (Lindholm
et al., 1992), and could thus be involved in mediating the persis-
tent downregulation ofmicroglia and astrocytes in the absence of
injury. To elucidate the function of endogenous TGF1 in the
CNS, we examined the effects of TGF1 deficiency on the unle-
sioned adult brain and then extended these studies to an experi-
mental model of CNS trauma and functional repair in the axoto-
mized mouse facial motor nucleus.
Materials andMethods
Animals
Wild-type (TGF1/) and homozygous TGF1-deficient
(TGF1/) adult mice (2 months of age) were obtained from the
laboratory of T. Doetschmann andmaintained on the RAG2-null immu-
nodeficient background to prevent lethal postnatal autoimmune inflam-
matory disease in the absence of TGF1 (Shull et al., 1992; Diebold et al.,
1995). The animals were bred on a mixed 129S6 CF-1 strain to avoid
the severe embryonic lethality thatwe and others observed in theTGF1-
null phenotype, preventing analysis in the adult mice (Kallapur et al.,
1999; Brionne et al., 2003). Both control/mice and the/ litter-
mates were generated as the F1 generation of crossing TGF1/ ani-
mals. For genomic screening, a short piece from the tail of 2-week-old
mice was incubated at 56°C overnight in proteinase K lysis buffer (100
g/ml; RocheDiagnostics,Mannheim,Germany). The lysate was treated
with phenol-chloroform and the genomic DNA was precipitated out of
solution with isopropanol, washed, and redissolved in 200 l of bidis-
tilled water. PCRwas then used to detect the neomycin cassette (Diebold
et al., 1995), using 0.5 l of genomic DNA template from the reverse
transcription reaction, 1 PCR buffer (Eurobio, Raunheim, Germany),
3.0 mM MgCl2, 200 M deoxynucleotide triphosphates (Pharmacia,
Freiburg, Germany), 1.0 U taq polymerase (Eurobio), and 10 pmol of the
sense primer (TGFS1; 5-GAG AAG AAC TGC TGT GTG CG-3) and
10 pmol of the antisense primer (TGFAS1; 5-GTG TCC AGG CTC
CAA ATA TAG G-3). A second PCR specific to the neomycin insert was
performed to confirm the genotypingof the first PCRusing the sense primer
(NeoS1; 5-GCC GAG AAA GTA TCC ATC AT-3) and the antisense
primer (TGFAS1). PCR was performed on a Biometra (Goettingen, Ger-
many) Thermoblock andwas initiated with a hot start using an initial dena-
turing temperatureof94°C for5minand in the subsequent cycles for45 s, an
annealing temperature of 56°C for 50 s, and an extension temperature of
72°C for 1 min for a total of 35 cycles, with a final extension for 10 min at
72°C and then cooling to 4°C. PCR products were analyzed using 1.5%
agarose gels, stained with ethidium bromide, and photographed.
Surgical procedures and tissue treatment
The right facial nerve was cut or crushed under tribromoethanol (Aver-
tin) anesthesia at the level of the stylomastoid foramen. The animals were
killed in ether or Euthatal after 0–28 d. For PCR, the brainstem was
removed immediately after the animals were killed and frozen on dry ice.
For light microscopy, animals were perfused with 200 ml of PBS (10 mM
Na2HPO4, 0.85% NaCl, pH 7.4), followed by 200 ml of 4% paraformal-
dehyde in PBS (PFA/PBS) and then by a 2 h immersion of the brainstem
in 1% PFA/PBS at 4°C on a rotator (8 rpm), an overnight rotating im-
mersion in a phosphate-buffered sucrose solution (PB; 10mMNa2HPO4,
pH 7.4, 4°C; 30% sucrose), and freezing on dry ice.
Regeneration, functional recovery, and central axonal sprouting
To determine the speed of facial axonal regeneration, the facial nerve was
crushed with a fine jeweler’s forceps for 30 s 1mm distal to the stylomas-
toid foramen. The animals were killed after 96 h as described by Werner
et al. (2000). After a brief, 5 min perfusion with PBS, and 5 min with 4%
PFA/PBS, the facial nerve was fixed by a slow, 60 min perfusion with 1%
PFA/PBS and then immediately dissected for a length of 15–20 mm and
frozen on dry ice. Nerves were cut longitudinally, and the regenerating
axons were visualized by immunostaining for galanin or for calcitonin
gene-related peptide (CGRP). Every fifth section was used per antibody,
with an interval of 50 m, and the distance between the most distal
labeled growth cone and the crush site was measured using light micro-
scopic grid scaling. The average distance for each animal was calculated
from four to five tissue sections.
Functional recovery in thewhisker hairmovementmodel was assessed
after facial nerve cut.Whiskermovementwas determined during the 28 d
postoperative period and scored on a 3 point scale [0 (no movement) to
3 (completely normal movement)] by blinded observers (Raivich et al.,
2004).
Axonal growth cones in and around the facial motor nuclei at day 14
(Kloss et al., 1999; Werner et al., 1999) were detected using standard
immunohistochemistry against galanin, the neuropeptide-positive pop-
ulation that normally shows strong sprouting in this axotomy model,
with a peak at 2 weeks after injury. Previous studies using retrograde
labelingwithMini-Ruby confirmed that these growth coneswere derived
from axotomized motoneurons (Werner et al., 1999). Quantification of
growth cones was performed by blinded observers on two sections per
facial nucleus, with an interval of 350 m between each section.
Light microscopic immunohistochemistry
Frozen brainstems were cut at the level of the facial nucleus, 20 m
sections were collected on warm, 0.5% gelatin-coated slides (Merck,
Darmstadt, Germany), refrozen on dry ice, and stored at 80°C until
further use. The sections were rethawed, pretreated for light microscopic
immunohistochemistry (LM-IHC) as described by Mo¨ller et al. (1996),
rehydrated in bidistilled water, spread onto the slide, dried for 5min, and
then incubated for 5 min in 4% PFA/PB, 2 min each in 50% acetone/
H2O, 100%acetone, 50%acetone/H2O, twice in PB, andPB/0.1%bovine
serum albumin (PB/BSA) (Sigma, Deisenhofen, Germany), and then
preincubated for 30min in PB/5%goat or donkey nonimmune serum, to
match the source of the final secondary or tertiary antibody (Vector
Laboratories, Wiesbaden, Germany). These preincubated sections were
incubated overnight at 4°C with the primary antibody and then for 2 h at
room temperature with appropriate biotinylated secondary antibody.
Source and dilution of all antibodies used are listed in Table 1. All incu-
bations with primary, secondary, and, where indicated, tertiary antibod-
ies were performed in PB/BSA, and finished by washing in three changes
of PB/BSA. The antibody specificity controls for the TGF receptor type
II (TGFRII) antibody were performed by incubating the antibody with
the TGFRII control peptide (s.c.-400-p; Santa Cruz Biotechnology,
Santa Cruz, CA) for 1 h at room temperature before applying themixture
on the tissue sections. Exposure to the biotinylated secondary antibody
was followed by 1 h of incubationwith the avidin–biotinylated horserad-
ish peroxidase complex (ABC; Vector Laboratories) and visualized with
diaminobenzidine (DAB; Sigma) and hydrogen peroxide (H2O2). The
reaction mixture consisted of 0.5 g/L DAB and 1:3000 dilution of 30%
H2O2 in PBS, pH 7.4, and was allowed to react for 5 min at room tem-
perature. After the DAB reaction, the sections were washed in distilled
water, dehydrated in graded alcohols and xylene, and mounted with
Depex.
Immunofluorescence double labeling, confocal microscopy,
and quantification
For immunofluorescence double labeling, the sections were simulta-
neously incubated with two primary antibodies: a monoclonal rodent
antibody from rat or hamster and a polyclonal antibody from rabbit
overnight, as for immunohistochemistry (see above and Table 1). The
sections were then incubated with two secondary antibodies, FITC-
conjugated goat anti-rat Ig and biotin-conjugated donkey anti-rabbit Ig,
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for 1 h at room temperature and then incubated with a tertiary FITC-
conjugated donkey anti-goat antibody and Texas Red-avidin (Dianova,
Hamburg, Germany) for 2 h. After final washing, the sections were cov-
eredwithVectaShield (Vector Laboratories) and stored in the dark at 4°C
for further use.
To record the immunofluorescence double labeling, digital micro-
graphs (1024  1024 pixels, 8 bit grayscale) of FITC and Texas Red
fluorescence were taken with a 10 objective (pinhole 30) in a Leica
(Bannockburn, IL) TCS 4D confocal laser microscope and represent
areas of 1  1 mm. The immunofluorescence was detected using low
ArKr laser power (0.3 V). Ten consecutive, equidistant levels were taken
per section (total vertical span, 30 m), condensed to a 1 MB TIFF
(tagged image file format) file for each fluorescence wavelength using the
MaxIntens condensation algorithm (which picks themaximum intensity
value for each pixel from the 10 available levels) and stored on amagneto-
optical disk. To extract spontaneous autofluorescence from the total
fluorescence recorded in the FITC andTexas Red channels, an additional
cyanin 5 (Cy5) bitmap was recorded using maximal laser power (3.0 V),
an excitation wavelength of 647 nm, andmaximal detector voltage with a
LP665 filter, and then treated the same way as the FITC and Texas Red
bitmaps.
For additional processing, the three corresponding bitmaps per facial
nucleus (FITC, TX Red, and Cy5) were transferred to OPTIMAS 6, and
corrected images were obtained by subtracting the autofluorescence
from the FITC and Texas Red images. Then linear extraction coefficients
for the FITC bitmap were determined by delineating highly autofluores-
cent structures in the Cy5 bitmap with a threshold of mean  5  SD,
these profiles were transferred to the FITC bitmap, and a quotient was
calculated,with the difference between themeanoptical luminosity value
(OLV; grayscale 0–255) of the pixels delineated by these profiles and the
overall mean OLV in the FITC bitmap in the numerator and the differ-
ence between the correspondingmeans of the Cy5 bitmap in the denom-
inator. The corrected FITC imageswere obtained by subtracting from the
OLV of each pixel in the original FITC bitmap the product of the OLV of
the corresponding pixel in the Cy5 bitmap and the linear extraction
coefficient for FITC. Corrected Texas Red images were obtained accord-
ingly and then used for quantification.
To quantify the microglial immunoreactivity for the early [M2 in-
tegrin and intercellular adhesion molecule 1 (ICAM1)], midphase
(61), and phagocytic (X2 and B7.2)
markers, the digital micrographs were pro-
cessed using the relative intensity of staining
coefficient (RISC) algorithm as described by
Werner et al. (1998). Cellular profiles were de-
lineated in the Texas Red image of ionized
calcium-binding adaptor protein-1 (IBA1) im-
munoreactivity using a mean  1.5  SD
threshold. The profiles were transferred to the
bitmap of the counterpart fluorescence for the
antibodies listed above, and the relative inten-
sity of staining coefficient for microglia in the
facial nucleus (RISCmicr) was determined ac-
cording to the following formula: RISCmicr
log(1  [OLVmicr  OLVfac]/OLVout), with
OLVmicr themeanOLV for themicroglial pro-
files in the facial nucleus, OLVfac the OLV for
the whole facial nucleus, and OLVout for the
tissue outside the facial nucleus. This mean
RISC was calculated for the axotomized and for
the contralateral, unoperated facial motor nu-
cleus within each animal group (n 3–7), and
the statistical significance between the
TGF1/ andTGF1/micewas tested at
a 5% level using an unpaired Student’s t test.
Quantification of cell numbers
Neurons. The brain tissue was postfixed for 2 d
in 4% buffered paraformaldehyde and cut in a
cryostat at15°C, and the 25m frontal tissue
sections were collected throughout both facial
nuclei (axotomized and contralateral) and stained with toluidine blue
(Nissl). Neuronal cell counts were corrected for neuronal cell body size
using Abercrombie correction.
Proliferating cells. To quantitate cell proliferation (2 and 3 d after axo-
tomy), the animals were injected with 200 Ci of [ 3H]-thymidine
(PerkinElmer, Wellesley, MA) 2 h before they were killed, perfusion
fixed, and cut as described previously (Raivich et al., 1994). The sections
were treated with an ascending alcohol dilution series (70, 90, 95, 100%
ethanol, 100% isopropanol) and xylene, rehydrated with a descending
alcohol dilution series to water and allowed to dry overnight, dipped in
NTB2 photoemulsion (diluted with equal volume distilled water), ex-
posed for 3 weeks at 4°C, developed with D-19 developer (Eastman
Kodak, Rochester, NY) for 2 min, rinsed in water for 1 min, fixed in
tetanal fixative (Eastman Kodak) for 4 min, rinsed in water, and then
allowed to dry. The labeled cells were counted for the whole facial motor
nucleus (six sections per animal; n 7).
Microglia and astrocytes.The facialmotor nucleus sections (two 20m
sections per animal, spaced 360mapart; n 4–8)were segmented into
six subsections of a 0.032 mm2 size; cell counts of GFAP-positive astro-
cytes or nucleated M2-positive microglia within each subsection were
converted to cells per square millimeter. Cell counts were made individ-
ually for the operated as well as the unoperated side. To determine
whethermicroglia was the only cell type undergoing proliferation (Grae-
ber et al., 1988), immunohistochemistry using M2 or GFAP antibod-
ies was performed on tissue sections from animals injected with [ 3H]-
thymidine, followed by treatment with alcohol, drying, and
autoradiography, as described in the preceding paragraph.
In situ hybridization for TGF1, TGFRI, and TGFRII mRNAs
Probe synthesis. cDNA fragments corresponding to nucleotides
298–1233 ofmouse TGF1 (GenBank accession code NM_011577), nu-
cleotides 1539–2651 of mouse TGFRI (GenBank accession code
NM_009370), and nucleotides 2447–3244 ofmouse TGFRII (GenBank
accession code D32072) were generated by PCR and subcloned into the
pGEM-T easy vector (Promega, Madison, WI). [ 35S]-labeled ribo-
probes in sense and antisense direction were produced by in vitro
transcription as described previously (Heuer et al., 2000). After syn-
thesis, the probes were subjected to mild alkaline hydrolysis to gen-
erate fragments of 250 nt.
Table 1. Summary of antibodies
Antibody (code and type)
Antigen Primary Dilution Application Source
6 (61) GoH3, RtM 1:3000 DIF Camon, Wiesbaden, Germany
M (M2) 5C6, RtM 1:6000 DIF Camon
X (X2) N418, HmM 1:100 DIF Endogen, Hamburg, Germany
B7.2 09271D, RtM 1:3000 DIF BD Pharmingen, Hamburg, Germany
CGRP -CGRP, RbP 1:400 IHC Peninsula, Belmont, CA
CD44 -CD44, RtM 1:5000 IHC, DIF Millipore, Billerica, MA
Galanin RGG-7141, RbP 1:400 IHC Peninsula
GFAP Z334, RbP 1:6000 IHC, DIF Dako, Hamburg, Germany
IBA1 -IBA1, RbP 1:6000 DIF Dr. Imai, Department of Neurochemistry, National
Institute of Neuroscience, Tokyo, Japan
ICAM1 -ICAM1, RtM 1:3000 DIF Camon
MHC1 ER-HR52, RtM 1:250 DIF BMA Biomedicals, Augst, Switzerland
TGFRII sc-400, RbP 1:2000 IHC Santa Cruz Biotechnology, Santa Cruz, CA
Secondary and tertiary
Goat Ig FITC-cj-Gt Ig, DkP 1:100 DIF Dianova, Hamburg, Germany
Hamster Ig FITC-cj-Hm Ig, GtP 1:100 DIF Dianova
Rat Ig Biotinylated-Rt Ig, GtP 1:100 IHC Vector Laboratories
Rat Ig FITC-cj-Rt Ig, GtP 1:100 DIF Dianova
Rabbit Ig Biotinylated-Rb Ig, 1:100 IHC Vector Laboratories
GtP
Rabbit Ig Biotinylated-Rb Ig, 1:100 DIF Dianova
DkP
RtM, Ratmonoclonal; HmM, hamstermonoclonal; RbP, rabbit polyclonal; DkP, donkey polyclonal; FITC-cj, fluorescein isothiocyanate conjugated; DIF, double
immunofluorescence.
Makwana et al. • Trophic and Anti-Inflammatory Role of TGF1 in Adult Brain J. Neurosci., October 17, 2007 • 27(42):11201–11213 • 11203
Combined IHC and in situ hybridization. For
colocalization experiments, cryosections were
first stained with the monoclonal antibody
against the microglial marker M2 integrin,
followed by incubation with a biotinylated sec-
ondary antibody and ABC complex (Vector
Laboratories) as described above. To prevent
RNA degradation, all incubation steps were
performed in the presence of 10 U/ml RNase
inhibitor (Ambion, Austin, TX). After the per-
oxidase staining reaction with DAB/H2O2, the
respective transcripts were localized by in situ
hybridization as described by Friedrichsen et al.
(2005). Briefly, the sections were fixed again
with 4% PFA solution in PBS for 1 h at room
temperature (RT) and treatedwith 0.4%Triton
X-100 in PBS followed by an acetylation step.
After dehydration, sections were covered with
hybridization mix containing radioactive
cRNA probes diluted in hybridization buffer
(50% formamide, 10% dextran sulfate, 0.6 M
NaCl, 10 mM Tris/HCl, pH 7.4, 1 Denhardt’s
solution, 100 g/ml sonicated salmon-sperm
DNA, 1 mM Na2EDTA, and 10 mM dithiothre-
itol) to a final concentration of 5 104 cpm/l.
After incubation at 58°C for 16 h, coverslips
were removed in 2 standard saline citrate
(SSC; 0.3 MNaCl and 0.03 M sodium citrate, pH
7.0). The sections were then treated with RNase
A (20 g/ml) and RNase T1 (1 U/ml) at 37°C
for 30min. Successive washes followed at RT in
1, 0.5, and 0.2 SSC for 20min each and in
0.2 SSC at 70° for 1 h. The tissue was dehy-
drated and exposed to x-ray film (BioMaxMR;
Eastman Kodak) for 68 h. For microscopic
analysis, sections were dipped in Kodak NTB2
nuclear emulsion and stored at 4°C for 2 weeks.
Autoradiograms were developed, stained with
cresyl violet, and viewed under dark- and
bright-field illuminations using an Olympus
(Tokyo, Japan) AX microscope.
Results
TGF1 deficiency causes gliosis
throughout adult brain
To determine the effects of TGF1 dele-
tion on the adult CNS, wild-type
(TGF1/) and homozygous deficient
(TGF1/) littermates were generated
as F1 generation crossing of the
TGF1/ parent animals. To prevent
lethal autoimmune inflammation nor-
mally occurring 2–3 weeks after birth
(Diebold et al., 1995; Bommireddy and
Doetschman, 2004), all animals were maintained on the RAG2-
null immunodeficient background (Engle et al., 1999). Despite
this background, homozygous deletion of TGF1 caused pro-
nounced, consistent, and very similar gliotic changes throughout
the CNS, affecting astrocytes, microglia, and perivascular
macrophages.
Astrocytes
TGF1 deficiency-mediated changes were already apparent at
lowmagnificationusing astrocyte immunoreactivity (IR) for glial
fibrillary acidic protein (GFAP-IR) (Fig. 1, compare A, E for
TGF1/ and B, F for TGF1/). In the TGF1/ con-
trol animals, GFAP-IR is confined to the stellar astrocytes in the
white matter, around meninges, ventricles, and large blood ves-
sels (Fig. 1A,E), and a few graymatter regions such as hippocam-
pus (Fig. 1A) and cerebellum (not shown). Protoplasmic astro-
cytes in most gray matter regions displayed very little to no
GFAP-IR, as shown for example at higher magnification for the
spinal nucleus of the trigeminal nerve (SNTN) in the brainstem
in Figure 1 I. In contrast, the TGF1/mice showed a general
increase in GFAP-IR, in the deep and superficial layers of the
dorsal cerebral cortex, throughout the ventral cortex, basal gan-
glia, reticular thalamic nucleus (Fig. 1B), and most parts of the
brainstem (Fig. 1F). Figure 1 J shows the extensive fibrillary as
well as diffuse GFAP-IR in the TGF1/ SNTN at higher
magnification.
Figure 1. Absence of TGF1 (TGF1/) causes strong glial changes throughout the adult brain, affecting astrocytes,
microglia, and perivascular macrophages. Massive increase in astroglial GFAP-IR in the TGF1/mice, in low-power magni-
fication of forebrain (A, B) and brainstem (E, F ), with intense labeling of the deep and superficial cortex, basal ganglia, and
reticular thalamic nucleus and inmost parts of the brainstem. E, F, The arrows point to the facial nucleus 3 d after axotomy setting
a contrast to the surrounding area in the TGF1/ animal but almost merging with background in TGF1/mouse. I, J,
The typical distributionofGFAP-IR at highermagnification in the spinal nucleus of the trigeminal nerve (spin trig nucl),with strong
labeling of astrocyte fibrils, aswell as in diffuse areas associatedwithprotoplasmic astrocytes in the TGF1/ animal. Absence
of TGF1 is associated with strong CD44 labeling of partly deramified microglia (arrows) and diffuse labeling of protoplasmic
astrocyte graymatter areas (M,N ) and increasednumber ofMHC2perivascularmacrophages (Q,R) but no change in the ICAM1
labeling of the vascular endothelium (U, V ). Absence of TGF1 causes strong reduction in the highly elaborate branching of
ramified microglia and M2 immunoreactivity throughout the adult forebrain and brainstem areas, including cortex,
hippocampus, striatum, corpus callosum, brainstemperiventricular areas (perivent), and cerebellum. Scale bar: (in X )A,B, 2mm;
E, F , 1 mm; I, J,M, N, Q, R, 150m; U, V , 200m; right two columns, 50m.
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Similar results were observed for the cell adhesion molecule
CD44 (Fig. 1M,N), which is almost completely absent frommost
gray matter regions of the normal, TGF1/ animals. In the
TGF1/ mice, CD44-IR was present throughout, labeling
protoplasmic astrocytes as well as amoeboid, microglia-like cells.
Follow-up experiments using double-labeling immunofluores-
cence for CD44 and a standard microglial marker, IBA1 (Imai et
al., 1996), confirmed the presence of CD44 on a large fraction of
IBA1-positive microglia in the TGF1/ but not TGF1/
mice (Fig. 2G,H), as well as in the GFAP-positive, velate astro-
cytes (Fig. 2K,L).
Microglia, macrophages, and blood vessels
Absence of TGF1 visibly affected perivascularmacrophages and
parenchymal microglia, but not the blood vessels. Compared
with the TGF1/ mouse brains, those from TGF1/ lit-
termates showed a twofold to threefold expansion in the number
of the perivascular macrophages with a strong immunoreactivity
for the major histocompatibility complex class 2 (MHC2) anti-
gen (Fig. 1Q,R), a typical marker of this perivascular cell type in
normal brain (Liu et al., 2005). In contrast, TGF1/ paren-
chymal microglia displayed a clear reduction in microglial cell
number, size, and staining for the M2 integrin, a typical and
constitutively expressedmicroglial cell marker (Perry et al., 1988;
Raivich et al., 1994), comparedwith their TGF1/ littermates
(Fig. 1C,D,G,H,K,L,O,P,S,T,W,X). Mutantmicroglia showed a
consistent loss of arborization, with shorter and stubbier pro-
cesses lacking tertiary and quaternary
branches. These morphological changes
were observed throughout the brain but
were somewhat more accentuated in the
brainstem regions.
Because inflammatory brain changes
can also affect blood brain vessels, with up-
regulation of endothelial cell adhesion
molecules such as the intercellular adhe-
sion molecule 1 (ICAM1), and alter trans-
migration of leukocytes and blood–brain
barrier function (Bohatschek et al., 2001),
we also investigated these parameters.
However, deletion of TGF1was not asso-
ciated with increased staining for blood
vessel ICAM1 (Fig. 1U,V). There was no
accumulation of endogenous peroxidase-
positive granulocytes in brain tissue; intra-
vascular injection of endogenous peroxi-
dase revealed an intact blood–brain
barrier (data not shown).
To determine the specific phenotype of
microglial changes in the TGF1/
mice, as a next step we explored the effects
of TGF1 deficiency on potential markers
of microglial activation, including cell
proliferation, early and midphase injury
response (61 and M2 integrins and
ICAM1), phagocytic phenotype (X2 in-
tegrin, B7.2, and MHC1), and additional
inflammatory markers such as CD44
(Jones et al., 2000). Double labeling with
antibodies againstM2 or IBA1was used
to identifymicroglial profiles; cell prolifer-
ationwas detected 2 h after intraperitoneal
injection with [3H]-thymidine, a blood–
brain barrier-permeable nucleotide incor-
porated into newly synthesized DNA. In the absence of TGF1
(/), a subpopulation of microglia proliferate and strongly
express a panel of phagocytic and inflammatorymarkers (MHC1,
X2, B7.2, andCD44) throughout the affected CNS (Fig. 2B,D,
F,H,J, respectively). None of these responseswere observed in the
normal brain of the/mice (Fig. 2A,C,E,G,I). In contrast to
the phagocytic phenotype, therewas noupregulation for the early
and midphase activation markers 61, M2, and ICAM1 in
the control, / brain without additional injury (see Figs.
6C,G,K, 7A–C).
Ultrastructural changes: axonal dystrophy, focal demyelination,
and microglial phagocytosis
Because presence of neural debris and other phagocytosable ma-
terial is known to cause ramified microglia to lose terminal
branches and transform into amoeboid phagocytes (Bohatschek
et al., 2001), the phagocytic phenotype of microglia in the
TGF1/ mouse brain could be caused by a neurodegenera-
tive process producing cellular debris. To explore whether this is
the case, we examined ultrastructural changes in the brainstem
facialmotor nucleus and adjacent ventrobasal whitematter in the
TGF1/ and TGF1/ mice using transmission electron
microscopy. Compared with the / littermates, which ap-
peared to be completely normal (Fig. 3A), the TGF1/mice
showed occasional disturbances in axonal transport, with local
bulging of axons to accommodate the anterogradely and retro-
Figure 2. A–J, In the absence of TGF1 (tgf1/), microglia proliferate (compare A, B) and express a panel of late-
activation markers [MHC1 (C, D), X2 (E, F ), and B7.2 (I, J )] throughout the affected CNS, a response not observed in the
uninjured, normal brain (tgf1/).A,B,Microglial proliferation in the cerebellar peduncle, double labelingusing autoradiog-
raphy for tritiated thymidine and immunoreactivity for M2 integrin ( 3HT/M2). C–J, Double immunofluorescence, with
IBA1 in red. A subpopulation of activated microglia showed strong immunoreactivity for MHC1 (normal facial motor nucleus),
X2 (periventricular brainstem), B7.2 (cerebellar peduncle), and CD44 (spinal nucleus of the trigeminal nerve) in green. Note
the changes in microglial morphology, with elaborate microglial branching in sections from TGF1/ animals. In the
TGF1/ mice, this branching is almost completely lost in MHC1, X2, and B7.2 microglia, and also strongly
reduced in those that did not stain for these phagocytosis-associatedmarkers. K, L, TGF1 deficiency had a stimulatory effect on
the CD44/GFAP velate astrocytes in the CNSwhitematter, but somedouble-positive astrocyteswere also present in thenormal,
TGF1/mice (GFAP staining in red, CD44 staining in green). Scale bar: (in L) A, B, 75m; C–L, 25m.
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gradely transported material, particularly
mitochondria (Fig. 3B,C). Neurofilament
structure at the site of interruption was
frequently disorganized. The retrogradely
transported material also contained large
and round structures that may represent
mitochondrial fragments. As shown in
Figure 3B, affected axons sometimes also
became demyelinated in a focal manner,
with some parts of the axon losing and
some others maintaining the myelinated
state.
Axonal dystrophy and demyelination
was accompanied by morphological
changes in parenchymal microglia. Com-
pared with TGF1/ microglia, which
exhibited a typical slender perikaryal cyto-
plasm (Fig. 3E), microglia from
TGF1/ mice consistently revealed
numerous but moderately sized phago-
cytic inclusions, cell body engorgement,
and a swelling of proximal processes (Fig.
3F). In the facial nucleus, they also showed
abnormal attachment to neighboring neu-
rons with full apposition of their cell body
to the neuronal surface (Fig. 3D,G), a pro-
cess called synaptic stripping that is nor-
mally only observed after neuronal injury
(Blinzinger and Kreutzberg, 1968; Kalla et
al., 2001; Trapp et al., 2007). At higher
magnification, these TGF1/ adher-
ing microglia also displayed numerous
membranous ruffles with frequent, ho-
mophilic focal adhesions (Fig. 3D).
TGF1 deficiency in the injured
nervous system
Neuronal response to facial axotomy
TGF1-mediated effects on adult neuro-
nal response to injury (axonal regenera-
tion, central sprouting and neuronal cell
death)were assessed using thewell charac-
terized facial axotomy model. Axonal re-
generation was examined in the crushed
facial nerve 96 h after injury as described
by Werner et al. (2000). The axonal
growth front of the regenerating, CGRP-
or galanin-positive motoneurites was de-
tected in longitudinally cut, fixed, 10 m
thin facial nerve sections using IR for the
axonally transported neuropeptides
CGRP and galanin, and distance to the site
of the crush was determined with amicro-
scope grid. As shown in Figure 4A, there
was no statistically significant difference between the
TGF1/ and TGF1/ animals 4 d after crush (n  6
animals per group, mean SEM).Wild-type,/mice showed
a regeneration distance of 6.9 0.1mm for the CGRP- and 7.0
0.2 mm or the galanin-positive axons at day 4; homozygous,
TGF1/mice showed a 1–2% smaller regeneration distance.
Absence of effect on speed of regeneration was mirrored by
typical biochemical changes in axotomized motoneurons that
did not differentiate between TGF1/ and / litter-
mates (for example, the induction of neuropeptides such as
galanin and cell adhesion molecules such as CD44) (Raivich et
al., 2004). Galanin-IR was strongly upregulated after axotomy
in normal TGF1/mice, with a peak 7 d after injury. Here,
the absence of TGF1 did not lead to a significant difference in
the expression of this neuropeptide at any of the four time
points studied (days 2, 3, 7, and 14) (data not shown). Absence
of TGF1 also did not affect CD44, with more or less identical,
strong increase in neuronal CD44-IR in the wild-type and
Figure 3. Ultrastructural changes in the brain of TGF1-deficient,/mice. A, E, Normal axons, microglia (m), and astro-
cytes (a) in the control, TGF1/ animals. B, C, TGF1/ mice show frequent disturbances in axonal transport. These
disturbances lead to the local bulging of axons to accommodate the anterogradely and retrogradely transportedmaterial, partic-
ularly mitochondria, in the proximal (prox) and distal (dist) parts of the axon, respectively. Affected axons sometimes become
partly demyelinated (proximal segment). As shown in B (inset), microtubular structure at the site of interruption (arrows) is
frequently disorganized and displaced. Retrogradely transported material accumulating in the distal part also contains large and
round breakdown organelles (asterisks) thatmay representmitochondrial fragments.D, F,G, Themicroglia in TGF1/mice
consistently show areas with numerous, moderate-size phagocytic inclusions (asterisks and F, inset) that extend into swollen
proximal processes (F ). They also exhibit an abnormal attachment to neighboringneurons (N) and, at highermagnification,many
membranous ruffles with frequent, homophilic focal adhesions (D). Scale bar: (inG) A,B, 0.8m;B inset, 0.3m; C, 1.5m;D,
0.4m; E–G, 2.5m.
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TGF1-deficient animals in the axotomized facial nucleus
(data not shown).
To next assess the more long-term functional recovery after
facial nerve cut, the overall movement of whisker hair, a key
target of facial innervation, was scored on a scale of 0 (no move-
ment) to 3 (strong, normal movement). Functional recovery was
somewhat slower in the TGF1/ (F(1,113)  33.46 in multi-
way ANOVA; p  0.0001), but the delay was moderate, with
almost complete recovery by day 28 (Fig. 4B).
TGF1 deficiency also interfered with central axonal sprouting
(Fig. 4D–H). Facial axotomy normally leads to enhanced axonal
sprouting, with a maximum at day 14 (Werner et al., 1999; Galiano
et al., 2001) (Fig. 4D,E), which is absent on the contralateral side
(Fig. 4F,G). Control, TGF1/ animals showed the prominent
sprouting of the galanin-positive axons (Fig. 4D); the TGF1/
mice revealed a 40% reduction in total number of axonal growth
cones (Fig. 4H),withacompletedisappearanceof these structures in
the basal stripe of central white matter ven-
tral to the facial motor nucleus (Fig. 4E).
A substantial number of neurons die
after nerve transection, probably because
of failed target reinnervation and subse-
quent lack of trophic support (Sendtner et
al., 1996). To assess whether TGF1 plays
a role in axotomy-induced neuronal cell
death, all motoneurons in the facial motor
nucleus were counted using 25 m cresyl
violet-stained serial brain sections and
corrected for cell size using Abercrombie
correction. One month after facial nerve
transection, axotomy had caused a loss of
13% in the injured facial motor nucleus of
control mice (1674  69 compared with
1936 22 on the unoperated side; n 9).
In TGF1/ mice, neuronal loss by
axotomy was increased by approximately
fourfold, to 53%, with 822  77 neurons
on the axotomized and 1737  64 on the
unoperated side ( p  0.001 in unpaired
Student’s t test) (Fig. 4C). As in previous
studies (Galiano et al., 2001; Raivich et al.,
2002), neuronal cell size increased by an
average of 3–5% from 22 to 23 m on the
axotomized side, butwithout a statistically
significant difference between the
TGF1/ and TGF1/ groups.
However, the TGF1/ animals did
show a significant 10% reduction in facial
motoneuron number on the uninjured
side compared with the / controls
( p  0.025), pointing to an underlying
trophic role of TGF1 in the normal adult
brain as well as after peripheral axonal
injury.
Defective activation of glial cells in the
absence of TGF1
Nerve transection not only triggers
changes in affected neurons, but also re-
sults in reactive changes in adjacent astro-
cytes and rapid activation and prolifera-
tion of microglia. Both sets of responses
were affected in TGF1/ mice, but in
opposite directions.
Cell proliferation
Microglial proliferation normally peaks 2–3 d after peripheral
nerve injury (Raivich et al., 1994). Compared with their
TGF1/ littermates, TGF1/mice showed a 70–75% re-
duction in the rate of [3H]-thymidine-labeled proliferating cells
at both time points ( p 0.05; n 7 per group; Student’s t test)
(Fig. 5A). Double labeling using [3H]-thymidine autoradiogra-
phy for proliferation and antibodies against standard microglial
and astrocyte markers (M2 integrin and GFAP, respectively)
confirmed all proliferating cells as M2-positive microglia in
control as well as TGF1/ mice, with no staining on the
GFAP-positive astrocytes (Fig. 5C,D,G,H). Total counts of mi-
croglia 7 d after peripheral nerve transection revealed similar
results (Fig. 5B), with a fourfold increase in the total number of
microglia in the affected facial motor nucleus compared with the
unoperated facial motor nucleus in the/ animals, and just a
Figure 4. TGF1 and axonal regeneration, sprouting, functional recovery, and neuronal cell death after facial axotomy. A, No
effect on the regeneration distance of CGRP- and galanin (Galn)-immunoreactive motor axon populations, 4 d after facial nerve
crush (mean SEM; n 6 animals per group). B, Functional recovery of whisker hair movement after facial nerve cut (n 10
/ and 7/ animals). *p 0.05 in unpaired Student’s t test (uSTT) between/ and/ groups. C, Changes in
neuronal cell number in the axotomized (ax) and contralateral (co) facial motor nucleus, 30 d after a left facial nerve cut. Absence
of TGF1 enhances neuronal cell disappearance after axotomy, from 13% of the injured neurons in the/ to	52% in the
/ animals. Note the	10% smaller neuronal cell number on the unoperated, contralateral side in the TGF1-deficientmice.
n 9/ and 6/mice; *p 0.025 in uSTT between the same side in/ and/mice; #p 0.001, uSTT for the
difference in the ratio of operated/unoperated side in / to / animals. D–H, Central sprouting of galanin-
immunoreactive axons in TGF1/ (D,F ) and/ facial nuclei (E,G), 14 d after facial nerve cut (14ax); co, contralateral side
(C, D); H shows the quantification of the growth cones per tissue section (n 3 animals per group). Under normal conditions,
facial axotomy causes an induction of neuronal galanin immunoreactivity and a proliferation of galanin-immunoreactive axonal
sprouts, particularly in thewhitemattermarked by double arrows just ventral to the facialmotor nucleus, peaking 14 d after facial
nerve cut. This axonal sprouting is strongly curtailed in the TGF1/mice (*p 0.05, uSTT). AFMN, Axotomized facial motor
nucleus. Scale bar, 250m.
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1.8-fold increase in the / mice ( p 
0.05 comparedwith the TGF1/; n 4;
unpaired Student’s t test).
Early microglial activation
TGF1 deficiency caused a drastic reduc-
tion in cell adhesion molecules ICAM1
and M2 and 61 integrin, which
serve as early (ICAM1 and M2) and
midphase (61) activation markers that
normally increase after injury (Figs.
6A–L, 7A–C). In all three cases, quantifi-
cation of the double-labeling immuno-
fluorescence with the microglial marker
IBA1 using the RISC algorithm (Werner
et al., 1998) showed a significant 70–
90% smaller increase in immunoreactiv-
ity after injury ( p  0.01; unpaired Stu-
dent’s t test), as well as a somewhat lower
level of expression on the control, unin-
jured side ( p  0.05).
Phagocytic phenotype
Late phagocytosis-associated microglial
markers (X2, B7.2, and IBA1) were
tested 14 d after facial axotomy, a time
point normally coinciding with a maxi-
mum in neuronal cell death (Mo¨ller et al.,
1996). Here, quantitative immunofluores-
cence showed a highly significant increase
in the uninjured facial motor nucleus of
TGF1/ mice (Figs. 6M–T, 7D–F)
( p 0.01). These animals also showed sur-
prisingly little additional increase on the
operated side at 14 d after facial nerve cut,
in contrast to the prominent increase ob-
served for these markers in the/mice.
Neuronal adhesion
TGF1 deficiency also affected microglial
adhesion to motoneurons as shown in Fig-
ure 5, E, F, I, and J. To identify most neuro-
nal profiles, the two largest populations of
neuropeptide-immunoreactive motoneu-
rons in the facial motor nucleus [those pos-
itive for CGRP and those positive for gala-
nin (Moore, 1989; Raivich et al., 1995)]
were detected with a mixture of anti-CGRP
and anti-galanin antibodies. In normal
mice, M2-positive microglia (green)
only adhere to the neuropeptide-positive
neurons (red) with their processes but not
with their cell bodies (Fig. 5E), with cell
body adhesion only observed after axotomy
(Fig. 5F). However, it is also present in un-
injured facial motor nuclei in the
TGF1/mice (Fig. 5, compare I, J).
Astrocytes
In addition to the strong reactive gliosis ob-
served in the uninjured brain shown in Fig-
ure 1, transection of the facial nerve in the
TGF1/ mice resulted in a more pro-
nounced astrogliosis than that observed in
Figure5. Cell proliferation,microglial response, and astrogliosis following facial nerve injury.A, Cell proliferation in the facial
motor nucleus, 2 and 3 d after nerve cut, shows a 70–75% reduction in the rate of [ 3H]-thymidine-labeled proliferating cells
(3HT) per tissue section in TGF1/ mice [*p 0.05; n 7 per group; unpaired Student’s t (Figure legend continues.)
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the normal, TGF1/ littermates (Fig. 5K–O). Strong increase
in the number of GFAP-positive stellar astrocytes was already
observed in the contralateral, unoperated facial motor nucleus
( p  0.05; n  4–8; Student’s t test) (Fig. 5O), and a similar
increase was also seen on the operated side. At early time points
(days 2 and 3), one could also see a moderate but significantly
higher difference in the number of GFAP astrocytes between
the control and operated sides in the TGF1/ mice, com-
pared with their / littermates, pointing to an additional, ex-
cessive astrogliotic response to injury in the absence of TGF1.
Regulation and cellular localization of TGF1 and TGF
receptors type I and II mRNA
To further determine possible sites of TGF1 synthesis and ac-
tion, we explored the regulation and localization of the mRNA
encoding TGF1 and its two composite receptor types TGFRI
and TGFRII using high-stringency in situ hybridization with
[35S]-labeled cRNA antisense probes, as shown in Figure 8. Facial
axotomy caused a gradual upregulation in the case of TGF1
mRNA, peaking at day 4 (Fig. 8B,F, J,N); in the case of TGFRI,
this wasmore rapid, with high levels of expression between days 1
and 14 (Fig. 8C,G,K,O). TGFRII mRNA only showed constitu-
tive expression (Fig. 8P). Substituting sense for antisense cRNA
caused disappearance of specific labeling as demonstrated for
TGFRI in Figure 8D.
Because microglia in normal as well as injured brain were
particularly strongly affected in the normal and injured brain, we
combined the in situ hybridization protocol with the immuno-
histochemistry for the M2 integrin as microglial cell marker
(Fig. 8A,E, I,M), to determine the cellular localization for
TGF1, TGFRI, and TGFRII. In the unoperated facial motor
nuclei as well as throughout the brainstem, the strongly labeled
clusters of TGF1 and TGFRI mRNA expression were specifi-
cally localized to the cell bodies of the M2-positive microglial
cells, with more moderate, diffuse labeling on adjacent larger
neuronal profiles (Fig. 8 J,K). Facial axotomy caused strong up-
regulation of mRNA encoding TGF1 on activated microglia
(Fig. 8B,F) and TGFRI on injured neurons (Fig. 8C,J). At the
peak of neuronal cell death at day 14 (Mo¨ller et al., 1996), both
mRNAs were particularly strongly expressed in the phagocytic
microglial clusters (Fig. 8N,O). Although moderate levels of
TGFRII mRNA expression were also observed on the
M2-positive microglial profiles, strong expression was con-
fined to neurons and did not change after facial axotomy (Fig.
8P). A similar, constitutive and primarily neuronal localization
was also observed for TGFRII immunoreactivity (Fig. 8H,L).
Discussion
The high level of TGF1 in normal adult brain is in contrast to
other cytokines and suggests an important neural function for
this constitutively expressed molecule. (Lindholm et al., 1992;
Raivich et al., 1999). As shown in the current study, endogenous
TGF1 is expressed by parenchymal microglial cells and exerts a
trophic and anti-inflammatory effect in the adult CNS. More-
over, these effects were present not only after additional injury,
but also without previous physical damage. TGF1/ animals
showed a strong neuroinflammatory response throughout the
brain, excessive astrogliosis, and proliferating microglia assum-
ing a phagocytic, deramified, and abnormally activated pheno-
type. Ultrastructurally, these changes were accompanied by local
disruptions in axonal transport and focal demyelination, provid-
ing a mechanism to generate neural debris and maintain micro-
glial phagocytes and astrocyte reactivity throughout the CNS.
The significant reduction in the number of normal facial mo-
toneurons in the uninjured facial motor nucleus underlines the
importance of constitutively expressed TGF1 in preventing
neuronal loss in the adult.
These neurodegenerative changes present under normal con-
ditions were enhanced after additional injury. After facial axo-
tomy, absence of TGF1 caused a fourfold increase in neuronal
cell death in the injured facial motor nucleus, reduced central
axonal sprouting, and delayed functional recovery. It further ex-
acerbated astroglial reaction and interfered with the normal re-
sponse of microglia, reducing proliferation and causing absence
of early activationmarkers whilemaintaining a strong phagocytic
phenotype. Proliferating microglia displaying normal injury-
mediated responses play a significant, trophic role in a variety of
disease and injury models (Schroeter et al., 2006; Streit, 2006;
Lalancette-Hebert et al., 2007); interference with this function
may greatly enhance the rate of loss among injured neurons ex-
posed to cell stress and already near the threshold of programmed
cell death.
TGF1 and neuronal survival
TGF1 belongs to a closely related family of anti-inflammatory
growth factors, TGF1, TGF2, and TGF3, which share the
same receptors, TGF receptor type I and type II (Feng and
Derynck, 2005), and exhibit common neurotrophic activities
(Unsicker and Strelau, 2000). In this study, the absence of TGF1
alone was sufficient to strongly increase adult neuronal cell death
after axonal injury, indicating that it is not completely compen-
sated by the cytokines TGF2 or TGF3. The presence of focal
axonal dystrophy in the central white matter around facial motor
nucleus in TGF/mice also shows that axonal injury already
occurs without additional external damage. This suggests a sim-
ilar mechanism causing the reduction inmotoneuron number in
the “normal” brain, the broad neuroinflammatory changes ob-
served across the CNS, and massively reduced survival after ax-
onal injury.
4
(Figure legend continued.) test (uSTT)]. B, Microglial cell number in the facial motor nuclei of
/ and/ mice, 7 d after facial nerve cut (nucleated M2-immunoreactive profiles
per 1mm2). TGF1/ animals showa twofold smaller cell number ofmicroglia (MG) on the
uninjured side, as well as just a 1.8-fold increase in cell number 7 d after injury, compared with
a fourfold increase in the/animals (*p0.05 inuSTT for thedifferencebetween the same
side in/ and/; #p 0.05 for the difference in the ratio of operated/control side in
/ and/; n 4 per group). C, D, G,H, Double labeling using [ 3H]-thymidine autora-
diography for proliferation and standard microglial and astrocyte markers, M2 integrin
(aM) and GFAP, respectively. OnlyM2microglia but not the GFAP astrocytes prolifer-
ate after facial axotomy. This does not change in the absence of TGF1, although the number of
proliferating (3HT)M2-immunoreactivemicroglia is smaller. E, F, I, J, Absence of TGF1
affects microglial adhesion to motoneurons. Both populations of neuropeptide (NP)-
immunoreactivemotoneuronswere detectedwith amixture of CGRPandgalanin antibodies.E,
In the/mice,M2microglia (green) only adhere to the neuropeptide-immunoreactive
neurons (red) with their processes but not with their cell bodies before axotomy (co). F, After
axotomy [3 d after facial nerve cut (3ax)], cell body adhesion is also observed. TGF1/
mice showmicroglial cell body adhesion on the uninjured (I ) as well as on the injured (J ) side.
K–O, Astrocyte response in the injured brain. K–N, GFAP immunohistochemistry 3 d after
transection of the right facial nerve. K, L, TGF1/mice show increased GFAP immunore-
activity on stellar, fibrillary astrocytes in the axotomized facialmotor nucleus (L; 3ax), compared
with the uninjured, contralateral side (K; co). M, N, Massive astrogliosis in the TGF1/
animal, with an additional increase in GFAP immunoreactivity after axotomy (N ). O, Quantifi-
cation of GFAP-IR cell profiles per tissue section, for the axotomized and contralateral sides and
the interside difference (diff), 2–14 d after facial nerve cut. At all time points, there was a
significant increase for each side in the TGF1/ animals, and early time points (days 2 and
3) also show a stronger increase in these mice (*p 0.05, uSTT; ns, not significant). Error bars
represent SEM. Scale bar: (in N ) C, D, G, H , 94m; E, F, I, J , 30m; K–N , 200m.
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Such a mechanism could also be re-
sponsible for the decreased central axonal
sprouting and functional recovery ob-
served in the TGF1/ mice, but indi-
rect changes should not be excluded. For
example, absence of TGF1 strongly en-
hances the astroglial and extracellular ma-
trix responses that correlate inversely with
central axonal sprouting (Logan et al.,
1994; Galiano et al., 2001). Inhibition of
TGF signaling interferes with Schwann
cell proliferation and cell death
(D’Antonio et al., 2006), which could af-
fect the speed of functional recovery after
peripheral injury. Such indirect effects
would also agree with the absence of
TGF1 effect on motoneurite outgrowth
on explanted central white matter (Ho et
al., 2000), the lack of TGF1-deletion ef-
fect on the regenerative growth elongation
rate of the CGRP and galanin-
immunoreactive motor axons (Fig. 4A),
and the lack of differences in neuronal bio-
chemical changes in / and / mice
at early time points after facial axotomy.
Glial effects
TGF action is initiated by the binding of
the active form of TGF to TGFRII fol-
lowed by the phosphorylation of TGFRI,
causing phosphorylation of Smad pro-
teins, their translocation to the nucleus,
and transcriptional activation of target
genes (Feng and Derynck, 2005). In the
current study, the mRNAs encoding all
three components appear present on neu-
rons and microglia. However, there are
differences in the expression level in the
normal, uninjured brain, with high tran-
script levels for TGF1 and TGFRI on
the microglia and TGFRII mRNA and
protein in the neurons. TGF1 and
TGFRI are strongly upregulated, in a co-
ordinated manner, in both neurons and
microglia during the early phase of glial
and neuronal response, 1–4 d after facial
axotomy. At later stages, their levels gener-
ally decline on both microglia and neu-
rons, but leave persisting strong expres-
sion on the phagocytic microglial clusters
labeledwith the thick arrows in Figure 8,N
and O. On a cellular level, the apparently
coordinated presence of the cytokine as well as both receptor
components would permit both autocrine stimulation and a bi-
directional, neuron-to-microglia and microglia-to-neuron ex-
change of signals. Nevertheless, the peak period of expression in
the first week after injury, the absence of TGF1 deficiency-
mediated changes in early axonal regeneration and neuronal
markers, and the strong effects on astrocytes, but particularly on
the early microglial activation, could suggest that these glial cells
are the primary target of the TGF1 action.
Activation of microglia normally proceeds in stages (Kloss et
al., 1999; Raivich et al., 1999; Boucsein et al., 2000), encompass-
ing initial state of alert with the induction of early activation
markers (M2 and ICAM1), followed by homing onto dam-
aged cellular structures, expression of 51, and 61 brisk pro-
liferation, causing a fourfold to sixfold increase in increasing mi-
croglial cell number (Raivich et al., 1994; Klein et al., 1997).
Neural cell debris transforms microglia into phagocytes that re-
move this debris, express a third set of additional markers typical
of CNS phagocytes, associated with antigen presentation such as
MHC1 and costimulatory factors B7.2 and X2 integrin (Kloss
Figure 6. TGF1/ deficiency causes a split response in the regulation of early (ICAM1 and M2 integrin), midphase
(61), and phagocytic (X2 and B7.2) markers on microglia after facial axotomy (ax) and on the contralateral side (co).
Double immunofluorescence is shown with microglial IBA1 counterstaining in red and other labels in green. A–L, In the first
group, absence of TGF1 interferes with the upregulation of ICAM1 (A–D),M2 integrin (E–H ), and61 (I–L), normally
observed at days 2 and 3 in the TGF1/mice.M–T, In the second group, smallX2- (M–P) and B7.2-(Q–T ) immunore-
active microglia are already present in the contralateral facial motor nuclei in the TGF1/ mice; their numbers are barely
affected by facial axotomy. In control, TGF1/ animals, facial axotomy normally leads to the appearance of large,X2-
and B7.2-immunoreactive microglial nodules, peaking at day 14, that remove dead neuronal debris. Scale bar: (in T) A–L, 250
m;M–T, 330m.
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et al., 1999; Bohatschek et al., 2004a,b),
and engagewith incomingT-cells (Raivich
et al., 1999). Nevertheless, although high
levels of MHC1, B7.2, and X2 are
phagocyte selective, they are just addi-
tional markers. In fact, normal microglial
phagocytes also express particularly high
levels of molecules turned on earlier, in-
cluding M2, 51, 61, and ICAM1
(Werner et al., 1998; Kloss et al., 1999).
In the current study, absence of TGF1
interfered with microglial changes in the
first and second phase, causing a strong
reduction in the axotomy-mediated in-
duction of M2 and ICAM1 adhesion
molecules and proliferation, and an al-
most complete inhibition of the 61 in-
crease. The reduction in proliferation is
surprising in view of previous in vitro data
demonstrating enhanced microglial pro-
liferation after neutralization of endoge-
nous TGF1 (Jones et al., 1998). The rea-
sons for the currently observed reduction
are unclear. These could be a partial ex-
haustion of proliferative capacity as a re-
sult of the persistent, previous prolifera-
tion in the TGF1/ brain, or
inhibitory effects of TGF1 deficiency on
the production of putative microglial mi-
togens by axotomized neurons. Interest-
ingly, absence of TGF1 did not interfere
with the process of phagocytosis. In fact,
the selective phagocytic markers were al-
ready expressed normally throughout the
brain of the TGF1-deficient animals, as
well as in uninjured facial motor nucleus.
Both in vitro and in vivo, phagocytosis of
increasing amounts of neural debris re-
sults in a step-by-step loss of microglial
branching (Mo¨ller et al., 1996; Bohatschek
et al., 2001). In fact, the current reduction
in ramification observed throughout the
brain in the TGF1/ animals is in
agreement with a moderate production of
cell debris throughout the brain as a result
of the inflammatory and neurodegenera-
tive process initiated by the complete ab-
sence of TGF1.
Surprisingly, there is an apparent lack
of upregulation in activationmarkers such
as ICAM1 and 61, as well as the low
levels of M2, on phagocytic cells
throughout the brain in the uninjured
TGF1-deficient animals, similar to that
observed in the injured, TGF1/ facial
motor nuclei. For example, the absence of
61 and ICAM1 and related cell surface
components could contribute to the ab-
normal autoadhesion observed with the
TGF1/ microglia in Figure 3, D and
G. Beyond this, one attractive hypothesis is
that these and many similar early-induced
microglial molecules that are maintained
Figure 7. Quantitative immunofluorescence for early and late microglial activation markers in the axotomized and
contralateral facial motor nucleus (open bars, unoperated side; filled bars, axotomized side) forM2 integrin (A; day 2),
ICAM1 (B; day 2),61 (C; day 3),X2 (D; day 14), B7.2 (E; day 14) and IBA1 (F; day 14) using RISC algorithm. *p 0.05
in unpaired Student’s t test for/ versus/ comparisons for the contralateral versus contralateral or axotomized
versus axotomized side; #p 0.05 for the comparison of the difference between the two sides in/ versus/
animals. The TGF1/ mice show a generally lower level of early markers ICAM1, M2, and 61 on the unoper-
ated side, a much smaller increase of ICAM1, M2, and 61 after injury, and high levels of X2, B7.2, and IBA1 on
the uninjured side. Error bars represent SEM.
Figure 8. Regulation and localization of TGF1 (beta1; B, F, J, N ), TGFRI (R1; C, G, K, O) and TGFRII (R2; P) mRNA and
TGFRII protein (H, L) using in situ hybridization with [ 35S]-labeled cRNA antisense probes (ish) and immunohistochemical (ihc)
techniques. Facial axotomy caused pronounced upregulation of TGF1 and TGFRImRNAs onmicroglia and neurons but did not
affect the strong constitutive, primarily neuronal expression of TGFRII mRNA and protein-IR. A–D, 1 d;H, L, 3 d; E–G, 4 d; I–K,
7 d; M–P, 14 d after axotomy. D, The level of nonspecific in situ hybridization labeling with a sense probe for TGFRI. The
high-magnification insets show colocalization with neurons (open arrows), M2-positive microglia (simple arrows), and
phagocytic microglial clusters (thick arrows) using combined staining forM2 integrin and in situ hybridization. Insets on the
right (all except J andK ) show the situation on the axotomized, and insets on the left (J,K ) show theuninjured, contralateral side.
The two left columns show low-magnification, bright-field and dark-field illuminated micrographs of combinedM2/TGF1
mRNA double staining; in each case, the axotomized side (right) is marked by asterisks. 3ax, 3 d after axotomy; co, contralateral
side. Scale bar: (in D) A–G, I–K,M–P, 1.2 mm; H, L, 200m; all insets, 70m.
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during phagocytosis are required to protect damaged neural tis-
sue or to counteract the damaging effects of molecules first pro-
duced by microglial phagocytes. Thus, phagocytic microglia are
alsomainly responsible for the synthesis of potentially neurotoxic
molecules, including TNF, Fas, nitric oxide, and glutamate-like
substances, associated with axonal dystrophy, focal demyelina-
tion, andneuronal cell loss (Merrill andZimmerman, 1991; Raiv-
ich et al., 2002; Stagi et al., 2005; Taylor et al., 2005; Domercq et
al., 2007). This microglia-first notion may be supported by the
fact that, in the absence of additional damage, neuron-selective
expression of inactivatedTGFRII does not seem to be associated
with pronounced neurodegeneration or glial response in the
4–10month young adultmice, despite the strong effects in block-
ing TGF-mediated neuroprotection in cell culture (Tesseur et
al., 2006).
Nevertheless, because all three main cell types (neurons, as-
trocytes, and microglia) were affected in the TGF1/ mice,
they could also contribute to the neurodegenerative changes in
these mutant mice. Thus, a direct elucidation of the cause-and-
effect scenario using cell-type specific inactivation of TGF-
mediated effects will considerably enhance the understanding of
the neural effects of this crucial anti-inflammatory and neuro-
protective cytokine.
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